Hypermethylated promoter profiles were related to IDH mutation, yet not randomly in IDH-mutated gliomas, because LATS2 promoter hypermethylation was more frequent in oligodendroglioma than in astrocytoma. This evidence concerns the gene IDH1 and central nervous system cancer.